Dr Tristan Zaide, PT, DPT - Medicare Physical Therapist in Middle Village, NY

Dr Tristan Zaide, PT, DPT is a medicare enrolled "Physical Therapist - Geriatrics" provider in Middle Village, New York. His current practice location is 8525 60th Rd Apt 2a, Middle Village, New York. You can reach out to his office (for appointments etc.) via phone at (516) 476-4928.

Dr Tristan Zaide is licensed to practice in New York (license number 025847) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1134509029.

Contact Information

Dr Tristan Zaide, PT, DPT
8525 60th Rd Apt 2a,
Middle Village, NY 11379-5464
(516) 476-4928
Not Available



Healthcare Provider's Profile

Full NameDr Tristan Zaide
GenderMale
SpecialityPhysical Therapist - Geriatrics
Location8525 60th Rd Apt 2a, Middle Village, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1134509029
  • Provider Enumeration Date: 06/04/2015
  • Last Update Date: 06/04/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 4284049842
  • Enrollment ID: I20210213000001

Medical Identifiers

Medical identifiers for Dr Tristan Zaide such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1134509029NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2251G0304XPhysical Therapist - Geriatrics 025847 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Tristan Zaide allows following entities to bill medicare on his behalf.
Provider NameFox Rehabilitation Physical Therapy Services Llc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1174560650
PECOS PAC ID: 1355395179
Enrollment ID: O20061023000060

News Archive

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.

The Lancet publishes new Seminar on MERS

Middle East respiratory syndrome (MERS) has recently returned to the headlines as new cases have been exported to Korea and China. Experts are concerned that MERS cases continued to be detected in Saudi Arabia throughout the past year, and there appears to be little reduction in the number of cases since its first discovery three years ago. As the month of Ramadan approaches, with 1 million pilgrims expected to arrive in Saudi Arabia in June and July 2015, MERS remains a threat to global health security.

Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds

A study conducted by a multidisciplinary Spectrum Health neurology team has found that dementia patients are not undergoing evaluation at the onset of the dementia process, a delay that prevents early, beneficial treatment.

Cancer screening updates

Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.

STRIVE study to assess safety, efficacy of rVSV-ZEBOV candidate Ebola vaccine

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences and the Sierra Leone Ministry of Health and Sanitation, is now enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE).

Read more Medical News

› Verified 6 days ago

Provider NameRehab On Wheels Ot Pt Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1245754225
PECOS PAC ID: 0042585358
Enrollment ID: O20171011003184

News Archive

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.

The Lancet publishes new Seminar on MERS

Middle East respiratory syndrome (MERS) has recently returned to the headlines as new cases have been exported to Korea and China. Experts are concerned that MERS cases continued to be detected in Saudi Arabia throughout the past year, and there appears to be little reduction in the number of cases since its first discovery three years ago. As the month of Ramadan approaches, with 1 million pilgrims expected to arrive in Saudi Arabia in June and July 2015, MERS remains a threat to global health security.

Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds

A study conducted by a multidisciplinary Spectrum Health neurology team has found that dementia patients are not undergoing evaluation at the onset of the dementia process, a delay that prevents early, beneficial treatment.

Cancer screening updates

Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.

STRIVE study to assess safety, efficacy of rVSV-ZEBOV candidate Ebola vaccine

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences and the Sierra Leone Ministry of Health and Sanitation, is now enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE).

Read more Medical News

› Verified 6 days ago

Provider NameLink Home Therapy Services Of Ny-pt Ot Slp Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1942782966
PECOS PAC ID: 2466704713
Enrollment ID: O20181015001509

News Archive

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.

The Lancet publishes new Seminar on MERS

Middle East respiratory syndrome (MERS) has recently returned to the headlines as new cases have been exported to Korea and China. Experts are concerned that MERS cases continued to be detected in Saudi Arabia throughout the past year, and there appears to be little reduction in the number of cases since its first discovery three years ago. As the month of Ramadan approaches, with 1 million pilgrims expected to arrive in Saudi Arabia in June and July 2015, MERS remains a threat to global health security.

Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds

A study conducted by a multidisciplinary Spectrum Health neurology team has found that dementia patients are not undergoing evaluation at the onset of the dementia process, a delay that prevents early, beneficial treatment.

Cancer screening updates

Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.

STRIVE study to assess safety, efficacy of rVSV-ZEBOV candidate Ebola vaccine

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences and the Sierra Leone Ministry of Health and Sanitation, is now enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE).

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tristan Zaide is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Tristan Zaide, PT, DPT
8525 60th Rd Apt 2a,
Middle Village, NY 11379-5464

Ph: () -
Dr Tristan Zaide, PT, DPT
8525 60th Rd Apt 2a,
Middle Village, NY 11379-5464

Ph: (516) 476-4928

News Archive

GeNOsys sponsors Phase I safety trial in collaboration with Nitric Solutions

GeNOsys, Inc. today announced they are sponsoring a Phase I safety trial in collaboration with Nitric Solutions Inc. GeNOsys will be testing their patented nitric oxide generator and nitric oxide producing formula for safety and effectiveness in treating disease. In a parallel study Nitric Solutions will be testing the efficacy of their prophilactic nitric oxide producing formula Nitrisol.

The Lancet publishes new Seminar on MERS

Middle East respiratory syndrome (MERS) has recently returned to the headlines as new cases have been exported to Korea and China. Experts are concerned that MERS cases continued to be detected in Saudi Arabia throughout the past year, and there appears to be little reduction in the number of cases since its first discovery three years ago. As the month of Ramadan approaches, with 1 million pilgrims expected to arrive in Saudi Arabia in June and July 2015, MERS remains a threat to global health security.

Dementia patients do not undergo diagnostic evaluation at onset of disease, study finds

A study conducted by a multidisciplinary Spectrum Health neurology team has found that dementia patients are not undergoing evaluation at the onset of the dementia process, a delay that prevents early, beneficial treatment.

Cancer screening updates

Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.

STRIVE study to assess safety, efficacy of rVSV-ZEBOV candidate Ebola vaccine

The Centers for Disease Control and Prevention (CDC), in partnership with the Sierra Leone College of Medicine and Allied Health Sciences and the Sierra Leone Ministry of Health and Sanitation, is now enrolling and vaccinating volunteers for the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE).

Read more News

› Verified 6 days ago


Physical Therapist in Middle Village, NY

Kinga Tarczalowicz,
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 8451 64th Rd Apt 1, Middle Village, NY 11379
Phone: 718-909-0076    
Mrs. Lisa Bisbano, PT, DPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 7252 Metropolitan Ave, Middle Village, NY 11379
Phone: 718-326-0055    
Lech Biernacki, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 6622 Gray St Apt 1, Middle Village, NY 11379
Phone: 917-515-1264    
Mr. Moustafa Abouelela, PHYSICAL THERAPY
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 6188 Dry Harbor Rd, 5e, Middle Village, NY 11379
Phone: 646-724-4459    Fax: 718-424-5070
Meriam Magtagad, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 7904 Metropolitan Ave, Middle Village, NY 11379
Phone: 718-894-2323    Fax: 718-894-5385
J Moon Physical Therapy Pc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 7945 Metropolitan Ave, Middle Village, NY 11379
Phone: 347-421-8173    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.